Valdagni R, Amichetti M, Pani G
Centro Oncologico, Istituti Ospedalieri, Trento, Italy.
Int J Radiat Oncol Biol Phys. 1988 Jul;15(1):13-24. doi: 10.1016/0360-3016(88)90341-0.
Between September 1985 and December 1986, 44 N3 (TNM-UICC) metastatic squamous cell cervical lymph-nodes were randomized to receive conventionally fractionated radical irradiation (RT) to a total dose of 64-70 Gy, or conventionally fractionated radical irradiation plus twice a week local microwave hyperthermia (Ht). The two major end points of this study were (a) local control rates evaluated at 3 months after the end of combined therapy and (b) incidence of acute local toxicity. Thirty-six nodes (82%) were evaluable as of December 1986, at which time there was a premature closure of this study due to ethical reasons. An interim analysis had revealed a statistically significant difference in complete response rates in favor of the combined arm (p = 0.0152). The complete response rates were 82.3% (14/17) for the combined treatment arm versus 36.8% (7/19) for the control irradiation arm, leading to an iso-dose thermal enhancement ratio (TER) value of 2.23. Both arms are comparable in average total RT dose delivered (RT: 67.05 Gy; RT + Ht: 67.85 Gy) and in average maximum node diameter (RT arm: 4.81 cm; RT + Ht: 4.88 cm). Acute local toxicities were similar in irradiated and heated plus irradiated neck regions; only one skin burn was observed. As possible treatment related death, one patient in the RT + Ht arm died 2 months after completion of therapy with a carotid rupture associated with extensive tumor necrosis. These results confirm previous non-randomized reports suggesting that hyperthermia in combination with full dose conventionally fractionated irradiation significantly enhances the chance of early local control of fixed N3 neck nodes without exhibiting an increase of acute local toxicity.
1985年9月至1986年12月期间,44例N3期(TNM-UICC)转移性宫颈鳞状细胞淋巴结被随机分为两组,一组接受常规分割的根治性放疗,总剂量为64 - 70 Gy;另一组接受常规分割的根治性放疗加每周两次的局部微波热疗(Ht)。本研究的两个主要终点是:(a)联合治疗结束后3个月评估的局部控制率;(b)急性局部毒性的发生率。截至1986年12月,36个淋巴结(82%)可进行评估,此时由于伦理原因该研究提前终止。一项中期分析显示,联合治疗组的完全缓解率存在统计学上的显著差异(p = 0.0152)。联合治疗组的完全缓解率为82.3%(14/17),而对照放疗组为36.8%(7/19),导致等剂量热增强比(TER)值为2.23。两组在平均总放疗剂量(放疗组:67.05 Gy;放疗 + 热疗组:67.85 Gy)和平均最大淋巴结直径(放疗组:4.81 cm;放疗 + 热疗组:4.88 cm)方面具有可比性。放疗颈部区域和热疗加放疗颈部区域的急性局部毒性相似;仅观察到1例皮肤烧伤。作为可能与治疗相关的死亡病例,放疗 + 热疗组的1例患者在治疗完成后2个月因颈动脉破裂伴广泛肿瘤坏死死亡。这些结果证实了先前的非随机报告,表明热疗与全剂量常规分割放疗相结合可显著提高固定N3颈部淋巴结早期局部控制的机会,且不会增加急性局部毒性。